Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase IB × Everolimus × Gynecologic × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 7 Endometrial Neoplasms 7 Fallopian Tube Neoplasms 4 Recurrence 3 Neoplasms 2 Breast Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Phase IB 1 Multiple Myeloma 1 Lung Neoplasms 1 Endometrial Hyperplasia 1 Colonic Neoplasms 1 Carcinoma, Ovarian Epithelial 1

Interventions

defactinib 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07318324 2026-01-06

Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer

M.D. Anderson Cancer Center

Phase 1 Not yet recruiting

Phase IB

Data powered by HemOnc (CC BY 4.0) Colophon ⚡